Molecular Genetics & Genomic Medicine, published by WILEY, is an esteemed and open-access journal that has been a prominent source of knowledge in the fields of genetics and molecular biology since its establishment in 2013. With an ISSN of 2324-9269, it aims to provide a platform for the dissemination of novel findings and innovative research that pushes the boundaries of genomics and its clinical applications. The journal holds a Q3 categorization in Genetics, Clinical Genetics, and Molecular Biology, reflecting its growing influence in these disciplines, as evidenced by its Scopus rankings. Researchers, professionals, and students alike will find valuable insights and advancements in genomic medicine, making this journal an essential resource for those dedicated to the understanding and application of genetic and molecular research in healthcare. Located at 111 River St, Hoboken, NJ, Molecular Genetics & Genomic Medicine continues to foster a global dialogue within the scientific community, ensuring accessible knowledge for all.

ACTA CYTOLOGICA is a premier journal dedicated to the field of cytology, offering a platform for researchers, professionals, and students interested in the intricate study of cellular biology and its applications in the medical domain. Published by KARGER in Switzerland, the journal has been a vital resource since its inception in 1960 and is recognized for its rigorous peer-reviewed articles. With a notable impact factor reflecting its significance—ranked in the Q2 category in both Medicine (miscellaneous) and Pathology and Forensic Medicine, and Q3 in Histology for 2023—ACTA CYTOLOGICA continues to contribute valuable insights into cytological research and its implications for clinical practice. The journal maintains an annual focus on cutting-edge studies and reviews that enhance understanding and methodological advancements in cytology. Although it does not provide open access, it remains an essential read for those involved in histology and pathology, promising to keep them abreast of the latest findings and technological innovations in the field.

Clinical Pathology, an esteemed journal published by SAGE Publications Ltd, stands at the forefront of advancing knowledge in the intersection of histology, microbiology, and pathology. As an Open Access journal since 2019, it provides researchers and healthcare professionals seamless access to high-quality, peer-reviewed articles that contribute to the field's growing body of knowledge. With a focus on enhancing diagnostic methodologies and advancing clinical applications, Clinical Pathology serves a diverse audience eager to explore innovative research and practical insights. The journal currently holds Q3 status in Histology and Pathology and Forensic Medicine, and Q4 in Medical Microbiology, reflecting its commitment to rigorous scholarship within a competitive landscape. Its ranking in Scopus further positions it as a vital resource for professionals striving for excellence in clinical and experimental pathology. We invite researchers, students, and professionals to engage with the latest findings and share their valuable contributions to help propel the field forward.

International Journal of Surgical Pathology is a distinguished peer-reviewed journal published by SAGE Publications Inc since 1993, specializing in the intricate fields of surgical pathology, anatomy, and surgery. With an ISSN of 1066-8969 and an E-ISSN of 1940-2465, this journal has been at the forefront of disseminating vital research that helps shape clinical practices and understanding in surgical diagnostics. Ranked in the Q2 category for Anatomy and garnering Q3 status in Pathology and Forensic Medicine as well as Surgery, the journal holds a commendable position within its field as reflected by its Scopus ranks. The impact factor underscores its influence and relevance, making it an essential resource for researchers, professionals, and students alike, looking to stay abreast of advancements in surgical pathology. However, please note that the journal does not currently offer open access options. As it converges through the years from 1993 to 2024, the International Journal of Surgical Pathology continues to uphold its commitment to excellence in medical research.

Veterinary Clinical Pathology, published by Wiley, stands as a crucial resource within the realm of veterinary science, particularly focusing on the intricate field of clinical pathology. Established in 1977, this journal has been at the forefront of advancing knowledge and research, with a converged publication timeline stretching to 2024. With an ISSN of 0275-6382 and an e-ISSN of 1939-165X, it is recognized for its rigorous contributions to the field, achieving a commendable Scopus rank of #87 in General Veterinary, placing it in the 55th percentile among its peers. While it operates under a subscription model, its impact is underscored by its Q2 ranking in the Veterinary category and Q3 in the broader Medicine category for 2023. As a platform for researchers, professionals, and students alike, Veterinary Clinical Pathology aims to disseminate significant findings, foster interdisciplinary collaboration, and enhance the understanding of pathophysiological processes in animals, ultimately contributing to better clinical outcomes and animal health management.

ENDOCRINE PATHOLOGY is a premier journal published by HUMANA PRESS INC, dedicated to advancing the understanding of endocrine disorders through innovative research and clinical practices. With an impressive impact factor and consistently ranked in the Q1 quartile across multiple categories such as Endocrinology, Diabetes and Metabolism, as well as Pathology and Forensic Medicine, this journal serves as a pivotal resource for researchers and professionals in the field. The journal covers a broad spectrum of topics related to endocrine pathology, providing insights into mechanisms, diagnostics, and therapeutics that inform both clinical and laboratory practices. Although it does not offer open access, its rigorous peer-review process ensures the dissemination of high-quality, impactful research that shapes clinical strategies and enhances patient care. With distribution spanning from its inception in 1990 to 2024, ENDOCRINE PATHOLOGY stands at the forefront of endocrine research, making it an essential read for anyone involved in the study and treatment of endocrine disorders.

Cardiogenetics, published by MDPI, is a leading open-access journal dedicated to advancing the field of genetics as it pertains to cardiovascular health and diseases. Since its launch in 2011, this journal has been at the forefront of disseminating high-quality research that explores the genetic underpinnings of cardiovascular conditions, offering a platform for innovative studies, reviews, and case reports. With an ISSN of 2035-8253 and an E-ISSN of 2035-8148, Cardiogenetics aims to bridge the gap between genetic research and clinical application, helping researchers, healthcare professionals, and students stay abreast of the latest advancements and findings. The journal’s commitment to open access ensures that its valuable content is available to a global audience, fostering greater collaboration and knowledge sharing in the cardiovascular genetics community. By contributing to this dynamic field, Cardiogenetics plays a crucial role in improving patient outcomes and paving the way for personalized medicine in cardiology.

The Journal of Molecular Diagnostics is a premier publication in the fields of molecular medicine and pathology, published by Elsevier Science Inc. With an impressive impact factor and recognized as a Q1 journal in both Molecular Medicine and Pathology and Forensic Medicine, this journal is dedicated to advancing the understanding and application of molecular diagnostics in clinical practice. The journal features rigorous peer-reviewed research, comprehensive reviews, and cutting-edge methodologies that highlight novel diagnostic tests and biomarkers. Researchers, professionals, and students in the biomedical sciences are invited to explore its diverse array of articles and contribute to a growing body of knowledge critical for innovation in healthcare delivery. Located in the Netherlands, the journal has secure its position among the top-tier journals with its recent Scopus ranking of 20th out of 208 in Medicine Pathology and Forensic Medicine, reflecting a strong percentile ranking of 90th. With coverage spanning from 1999 to 2024, the Journal of Molecular Diagnostics remains a vital resource for anyone committed to the future of molecular research and diagnostics.

Applied Immunohistochemistry & Molecular Morphology, published by Lippincott Williams & Wilkins, stands as a pivotal resource within the fields of histology, medical laboratory technology, and pathology. With an ISSN of 1541-2016 and an E-ISSN of 1533-4058, this journal has been contributing significant research and advancements since its inception in 1996. It serves a diverse audience, including researchers, professionals, and students, aiming to enhance the understanding of immunohistochemical techniques and molecular morphology. Recognized for its quality, it holds category quartiles of Q3 in histology and Q2 in medical laboratory technology and pathology and forensic medicine as of 2023. The journal's rigorous peer-review process ensures that only the most impactful findings are disseminated, thus advancing the education and practice in these critical domains of study. Though it is not an open-access journal, it remains essential for keeping abreast of the latest methodological innovations and applications in pathology and laboratory science, as evidenced by its respectable Scopus rankings and the continual convergence of groundbreaking research published through 2024.

Cancer Cytopathology, published by Wiley, is an esteemed journal that plays a pivotal role in the fields of Cancer Research and Oncology. With a focus on the microscopic examination and analysis of cancerous cells, this journal serves as a crucial platform for disseminating high-quality research aimed at improving diagnostic techniques and therapeutic strategies. The journal holds an impressive Q2 ranking in both Cancer Research and Oncology as of 2023, emphasizing its influence and importance within the scientific community. Additionally, it is recognized in the top 76th percentile in Medicine - Oncology and the 63rd percentile in Cancer Research according to Scopus rankings. Operating from the United States, Cancer Cytopathology is dedicated to fostering cutting-edge research and exploration in cytopathology, providing essential insights into cancer progression and management. Researchers and practitioners alike will find this journal invaluable for staying on the forefront of advancements in cancer diagnostics.